[Novelties in the field of progression factors in chronic kidney disease].
The fight against chronic kidney disease is one of the most relevant aspects of nephrological practice, from both the perspective of clinical activity and research within the field of nephrology. In this brief article, we present in very summarized form some of the aspects in this field in the last year that the authors found of interest. Because the content of the next few pages was necessarily chosen on the basis of the authors' preferences, we assume that many other topics of great interest have been left out of this summary. In any case, we hope that this article will be interesting and useful and also serve as an subject of debate in nephrology forums.
Mora-Fernández
C
C
Servicio de Nefrologia y Unidad de Investigacion, Hospital Universitario Nuestra Senora de Candelaria, Santa Cruz de Tenerife, Spain.
Jarque
A
A
Getino
M A
MA
Sánchez
R
R
Lozano
L
L
Navarro
J F
JF
D000328:Adult; D000581:Amidohydrolases / Q000235:genetics / Q000502:physiology; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000097:blood; D002244:Carbon / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D018450:Disease Progression; D005260:Female; D015316:Genetic Therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000188:drug therapy / Q000196:embryology / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D010087:Oxides / Q000627:therapeutic use; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D014511:Uremia / Q000378:metabolism; D014527:Uric Acid / Q000097:blood
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010087:Oxides; D014527:Uric Acid; C018524:N,N-dimethylarginine; D002244:Carbon; C040896:AST 120; D001120:Arginine; D000581:Amidohydrolases; C059999:dimethylargininase
Novedades en el campo de los factores de progresión en la Enfermedad Renal Crónica.